4-BENZYL-9-METHYL-1-OXA-4,9-DIAZASPIRO[5.5]UNDECANE, 97.0%, 250mg

Dibenzo[b,d]furan-1-ylboronic acid, 97.0%, 25g

1-N-Boc-4-Cyano-piperidine, 96.0%, 5g

5-cyclohexyloxazole-4-carboxylic acid, 95.0%, 250mg

2-Phenyl-1-(thiophen-3-yl)butan-1-one, 97%, 100mg

(S)-5-methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, 97%, 250mg

GC capillary column ROTI®Cap-5, 60 m, 0.25 mm, 0.50 µm, 1 Piece(s)

4-(4-Methoxyphenyl)morpholine, 95.0%, 5g

6,6-Difluoro-1,4-oxazepane, 98%, 1g

4-Chloro-2-methoxy-6-methyl-pyrimidine, 95.0%, 5g

1-(5-Bromopyrimidin-2-yl)propan-1-one, 95.0%, 250mg

2-(4-Methoxy-2,3-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 25g

XY cross stage, 120 x 78 mm, for Oxion Inverso inverted microscopes